Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in Neuroscience

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    May 2017
  1. KOO JH, Jang YC, Hwang DJ, Um HS, et al
    Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-kappaB signaling pathway.
    Neuroscience. 2017 May 17. pii: S0306-4522(17)30341.
    PubMed     Text format     Abstract available


  2. GUO X, Liu T, Zhao D, Wang X, et al
    FGF18 protects against 6-hydroxydopamine-induced nigrostriatal damage in a rat model of Parkinson's disease.
    Neuroscience. 2017 May 11. pii: S0306-4522(17)30323.
    PubMed     Text format     Abstract available


    April 2017
  3. KUMBHARE D, Holloway KL, Baron MS
    Parkinsonism and dystonia are differentially induced by modulation of different territories in the basal ganglia.
    Neuroscience. 2017 Apr 12. pii: S0306-4522(17)30238.
    PubMed     Text format     Abstract available


    December 2016
  4. MANCINI M, Smulders K, Cohen RG, Horak FB, et al
    The Clinical Significance Of Freezing While Turning in Parkinson's Disease.
    Neuroscience. 2016 Dec 9. pii: S0306-4522(16)30680.
    PubMed     Text format     Abstract available


    November 2016
  5. CONRADSSON D, Paquette C, Lokk J, Franzen E, et al
    Pre- and unplanned walking turns in Parkinson's disease - effects of dopaminergic medication.
    Neuroscience. 2016 Nov 17. pii: S0306-4522(16)30637.
    PubMed     Text format     Abstract available


  6. EHGOETZ MARTENS KA, Lefaivre SC, Beck EN, Chow R, et al
    Anxiety provokes balance deficits that are selectively dopa-responsive in Parkinson's disease.
    Neuroscience. 2016 Nov 14. pii: S0306-4522(16)30624.
    PubMed     Text format     Abstract available


  7. ZHANG M, Mu H, Shang Z, Kang K, et al
    Genome-wide pathway-based association analysis identifies risk pathways associated with Parkinson's disease.
    Neuroscience. 2016 Nov 10. pii: S0306-4522(16)30617.
    PubMed     Text format     Abstract available


    October 2016
  8. ZHAO TT, Shin KS, Kim KS, Park HJ, et al
    Effects Of (-)-Sesamin On Motor And Memory Deficits In An Mptp-Lesioned Mouse Model Of Parkinson's Disease Treated With L-Dopa.
    Neuroscience. 2016 Oct 24. pii: S0306-4522(16)30582.
    PubMed     Text format     Abstract available


    September 2016
  9. SMITH ES, Hardy GA, Schallert T, Lee HJ, et al
    The impact of L-dopa on attentional impairments in a rat model of Parkinson's disease.
    Neuroscience. 2016 Sep 21. pii: S0306-4522(16)30460.
    PubMed     Text format     Abstract available


  10. GEORGIADES MJ, Gilat M, Ehgoetz Martens KA, Walton CC, et al
    Investigating motor initiation and inhibition deficits in patients with Parkinson's disease and freezing of gait using a virtual reality paradigm.
    Neuroscience. 2016 Sep 17. pii: S0306-4522(16)30457.
    PubMed     Text format     Abstract available


    August 2016
  11. PETERSON DS, Horak FB
    Effects Of Freezing Of Gait on Postural Motor Learning in People With Parkinson's Disease.
    Neuroscience. 2016 Aug 13. pii: S0306-4522(16)30380.
    PubMed     Text format     Abstract available


  12. DANEAULT JF, Carignan B, Sadikot AF, Duval C, et al
    Subthalamic deep brain stimulation and dopaminergic medication in Parkinson's disease: Impact on inter-limb coupling.
    Neuroscience. 2016 Aug 8. pii: S0306-4522(16)30366.
    PubMed     Text format     Abstract available


    July 2016
  13. FLORIN E, Pfeifer J, Visser-Vandewalle V, Schnitzler A, et al
    Parkinson subtype-specific Granger-causal coupling and coherence frequency in the subthalamic area.
    Neuroscience. 2016 Jul 5. pii: S0306-4522(16)30291.
    PubMed     Text format     Abstract available


    June 2016
  14. KANDIL EA, Abdelkader NF, El-Sayeh BM, Saleh S, et al
    Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats.
    Neuroscience. 2016 Jun 27. pii: S0306-4522(16)30279.
    PubMed     Text format     Abstract available


  15. MURRAY HC, Low VF, Swanson ME, Dieriks BV, et al
    Distribution of PSA-NCAM in normal, Alzheimer's and Parkinson's disease human brain.
    Neuroscience. 2016 Jun 7. pii: S0306-4522(16)30233.
    PubMed     Text format     Abstract available


    May 2016
  16. WANG M, Qu Q, He T, Li M, et al
    Distinct temporal spike and local field potential activities in the thalamic parafascicular nucleus of parkinsonian rats during rest and limb movement.
    Neuroscience. 2016 May 26. pii: S0306-4522(16)30190.
    PubMed     Text format     Abstract available


  17. BETANCOURT E, Wachtel J, Michaelos M, Haggerty M, et al
    The Impact of Biological Sex and Sex Hormones on Cognition in a Rat Model of Early, Pre-Motor Parkinson's Disease.
    Neuroscience. 2016 May 25. pii: S0306-4522(16)30200.
    PubMed     Text format     Abstract available


    February 2016
  18. XU K, Di Luca DG, Orru M, Xu Y, et al
    Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A receptors.
    Neuroscience. 2016;322:129-137.
    PubMed     Text format     Abstract available


  19. ZHAO F, Bi L, Wang W, Wu X, et al
    Mutations of glucocerebrosidase gene and susceptibility to Parkinson's disease: An updated meta-analysis in a European population.
    Neuroscience. 2016 Feb 8. pii: S0306-4522(16)00130.
    PubMed     Text format     Abstract available


  20. BELLEBAUM C, Kobza S, Ferrea S, Schnitzler A, et al
    Strategies in probabilistic feedback learning in Parkinson patients OFF Medication.
    Neuroscience. 2016 Feb 1. pii: S0306-4522(16)00103.
    PubMed     Text format     Abstract available


    January 2016
  21. MUSTAFA S, Martin HL, Burkly L, Costa A, et al
    The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease.
    Neuroscience. 2016 Jan 22. pii: S0306-4522(16)00062.
    PubMed     Text format     Abstract available


  22. PIERUCCINI-FARIA F, Jones JA, Almeida QJ
    Insight into dopamine-dependent planning deficits in parkinson's disease: a sharing of cognitive & sensory resources.
    Neuroscience. 2016 Jan 12. pii: S0306-4522(16)00038.
    PubMed     Text format     Abstract available


  23. SUN H, Liang R, Yang B, Zhou Y, et al
    Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson's disease.
    Neuroscience. 2016;317:65-75.
    PubMed     Text format     Abstract available


  24. VERVOORT G, Heremans E, Bengevoord A, Strouwen C, et al
    Dual-task related neural connectivity changes in patients with Parkinson' Disease.
    Neuroscience. 2016 Jan 4. pii: S0306-4522(16)00005.
    PubMed     Text format     Abstract available


    December 2015
  25. ANDRZEJEWSKI K, Budzinska K, Zaremba M, Kaczynska K, et al
    Hypoxic ventilatory response after dopamine D receptor blockade in unilateral rat model of Parkinson's disease.
    Neuroscience. 2015 Dec 17. pii: S0306-4522(15)01104.
    PubMed     Text format     Abstract available


    November 2015
  26. BERGHAUZEN-MACIEJEWSKA K, Wardas J, Kosmowska B, Domin H, et al
    Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.
    Neuroscience. 2015 Nov 25. pii: S0306-4522(15)01048.
    PubMed     Text format     Abstract available


    October 2015
  27. ZHANG QJ, Du CX, Tan HH, Zhang L, et al
    Activation and blockade of serotonin receptors in the prelimbic cortex regulate depressive-like behaviors in a 6-hydroxydopamine-induced Parkinson's disease rat model.
    Neuroscience. 2015 Oct 16. pii: S0306-4522(15)00923.
    PubMed     Text format     Abstract available


    September 2015
  28. FRANKE SK, van Kesteren RE, Wubben JA, Hofman S, et al
    Progression and recovery of parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.
    Neuroscience. 2015 Sep 30. pii: S0306-4522(15)00892.
    PubMed     Text format     Abstract available


  29. LINDENBACH D, Conti MM, Ostock CY, Dupre KB, et al
    Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia.
    Neuroscience. 2015 Sep 9. pii: S0306-4522(15)00828.
    PubMed     Text format     Abstract available


  30. TARD C, Delval A, Devos D, Lopes R, et al
    Brain metabolic abnormalities during gait with freezing in Parkinson's disease.
    Neuroscience. 2015 Sep 1. pii: S0306-4522(15)00804.
    PubMed     Text format     Abstract available


    August 2015
  31. DING H, Underwood R, Lavalley N, Yacoubian TA, et al
    14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3theta overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
    Neuroscience. 2015 Aug 24. pii: S0306-4522(15)00774.
    PubMed     Text format     Abstract available


    July 2015
  32. JI L, Wang Y, Zhu D, Liu W, et al
    White matter differences between multiple system atrophy (Parkinsonian type) and Parkinson's disease: a DTI study.
    Neuroscience. 2015 Jul 24. pii: S0306-4522(15)00684.
    PubMed     Text format     Abstract available


  33. LAZIC K, Petrovic J, Ciric J, Kalauzi A, et al
    Impact of anesthetic regimen on the respiratory pattern, EEG microstructure and sleep in the rat model of cholinergic Parkinson's disease neuropathology.
    Neuroscience. 2015 Jul 14. pii: S0306-4522(15)00634.
    PubMed     Text format     Abstract available


  34. HOBAN D, Howard L, Dowd E
    GDNF-secreting mesenchymal stem cells provide localised neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Neuroscience. 2015 Jul 9. pii: S0306-4522(15)00621.
    PubMed     Text format     Abstract available


  35. KEBER U, Klietz M, Carlsson T, Oertel WH, et al
    Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Neuroscience. 2015;298:302-17.
    PubMed     Text format     Abstract available


  36. LIU W, Jalewa J, Sharma M, Li G, et al
    Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Neuroscience. 2015 Jul 2. pii: S0306-4522(15)00595.
    PubMed     Text format     Abstract available


    May 2015
  37. MOUNSEY RB, Martin HL, Nelson MC, Evans RM, et al
    The effect of neuronal conditional knock-out of peroxisome proliferator-activated receptors in the MPTP mouse model of Parkinson's disease.
    Neuroscience. 2015 May 28. pii: S0306-4522(15)00490.
    PubMed     Text format     Abstract available


  38. HIKISHIMA K, Ando K, Komaki Y, Kawai K, et al
    Voxel-based morphometry of the marmoset brain: in vivo detection of volume loss in the substantia nigra of the MPTP-treated Parkinson's disease model.
    Neuroscience. 2015 May 23. pii: S0306-4522(15)00483.
    PubMed     Text format     Abstract available


  39. KHANG R, Park C, Shin JH
    Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice.
    Neuroscience. 2015;294:182-92.
    PubMed     Text format     Abstract available


  40. SANTIAGO RM, Tonin FS, Barbiero J, Zaminelli T, et al
    The nonsteroidal antiinflammatory drug piroxicam reverses the onset of depressive-like behavior in 6-OHDA animal model of Parkinson's disease.
    Neuroscience. 2015 May 18. pii: S0306-4522(15)00472.
    PubMed     Text format     Abstract available


    February 2015
  41. RUMPEL R, Hohmann M, Klein A, Wesemann M, et al
    Transplantation of fetal ventral mesencephalic progenitor cells overexpressing high molecular weight fibroblast growth factor 2 isoforms in 6-hydroxydopamine lesioned rats.
    Neuroscience. 2015;286:293-307.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: